Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ohio State University Comprehensive Cancer Center

Clinical trials sponsored by Ohio State University Comprehensive Cancer Center, explained in plain language.

Trials to join now! 56 Not yet recruiting 10 Not yet finished but already full! 27 Completed 26 Terminated 1

Promising combo study halted early: hope for advanced blood cancer patients

Disease control Terminated

This study tested a combination of two drugs, ruxolitinib and CPX-351, in people with advanced myeloproliferative neoplasms (MPN), a type of blood cancer that has progressed. The goal was to find the best dose and see if the combination worked better than CPX-351 alone. Only 12 p…

Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control

Last updated May 15, 2026 11:57 UTC